Delivery Order SPE2DB22D3301-SPE2DB24FZ3PM
Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $3,600.88 firm fixed-price delivery order is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025 and was competitively awarded with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,357.72, is a firm fixed-price delivery order for the supply of Ketorolac 30 mg/mL vials. The contract has a period of performance through June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,384.85 Firm Fixed Price Delivery Order is for the supply of Ketorolac 30 mg/ml vial, a non-steroidal anti-inflammatory drug, with a completion date of June 11, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,082,529 units of the pharmaceutical product Ketorolac 30mg/ml 25s. The $2,600.25 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on July 8, 2024 with a completion date of July 9, 2024. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ketorolac 30 mg/ml vials, a pharmaceutical product, to support various government agencies and healthcare programs. The contract, valued at $1,605.26, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen. The contract has an ultimate completion date of July 29, 2024 and is structured as a Firm Fixed Price Delivery Order, with no...
- This federal contract award, valued at $1,939.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4568105691 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed-price pricing type and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of Ketorolac 30 mg/ml vials to the Defense Logistics Agency (DLA). The $25,903.16 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 8, 2023 and was awarded on December 7, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,241.55 firm-fixed-price delivery order is for the supply of 4567454071 KETOROLAC 60 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a March 5, 2025 completion date and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,758.90, is a Firm Fixed Price delivery order for the supply of Ketorolac 30 mg/ml vials. The contract has an ultimate completion date of January 17, 2023 and was awarded on January 13, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $1,819.97 and is a Delivery Order type with a Firm Fixed Price pricing structure. It covers the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, with a period of performance through March 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...